Home
/
AbCellera Biologics Inc.
/
Financials
/
Quarterly
AbCellera Biologics Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AbCellera Biologics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$8.96M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$17.08M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$4.24M
May 8, 2025
Q3
2025
Sep 30, 2024
$6.51M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$7.32M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$9.95M
May 8, 2025
Q3
2024
Sep 30, 2023
$6.60M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$10.06M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$12.19M
May 7, 2024
Q3
2023
Sep 30, 2022
$101.38M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$45.92M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$316.58M
May 4, 2023
Q3
2022
Sep 30, 2021
$5.51M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$27.64M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$202.74M
May 10, 2022
Q3
2021
Sep 30, 2020
$9.36M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$11.23M
Aug 13, 2021
Q1
2021
Mar 31, 2020
$4.66M
May 14, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($57.12M)
Nov 6, 2025
Q3
2025
Jun 30, 2025
($34.73M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($34.73M)
Aug 7, 2025
Q2
2025
Mar 31, 2025
($45.62M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($45.62M)
May 8, 2025
Q3
2025
Mar 31, 2025
($45.62M)
Nov 6, 2025
Q3
2025
Sep 30, 2024
($51.11M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
($36.93M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($36.93M)
Aug 7, 2025
Q2
2025
Mar 31, 2024
($40.61M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($40.61M)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($40.61M)
May 8, 2025
Q3
2024
Sep 30, 2023
($28.61M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($30.53M)
Aug 6, 2024
Q3
2024
Jun 30, 2023
($30.53M)
Nov 4, 2024
Q3
2024
Mar 31, 2023
($40.11M)
Nov 4, 2024
Q1
2024
Mar 31, 2023
($40.11M)
May 7, 2024
Q2
2024
Mar 31, 2023
($40.11M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
$26.62M
Nov 2, 2023
Q2
2023
Jun 30, 2022
($6.79M)
Aug 3, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($76.28M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($49.59M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($62.66M)
May 8, 2025
Q3
2025
Sep 30, 2024
($93.66M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($93.45M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($54.89M)
May 8, 2025
Q3
2024
Sep 30, 2023
($54.89M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($51.39M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($64.87M)
May 7, 2024
Q3
2023
Sep 30, 2022
$37.74M
Nov 2, 2023
Q2
2023
Jun 30, 2022
($8.40M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
$224.95M
May 4, 2023
Q3
2022
Sep 30, 2021
($28.10M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($7.03M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
$158.07M
May 10, 2022
Q3
2021
Sep 30, 2020
($1.77M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($854.0K)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($2.12M)
May 14, 2021